International Journal of Health Policy and Management

International Journal of Health Policy and Management

New Health Technologies: A UK Perspective; Comment on “Providing Value to New Health Technology: The Early Contribution of Entrepreneurs, Investors, and Regulatory Agencies”

Document Type : Commentary

Authors
Nassim Parvizi 1
Sahar Parvizi 2
1 Oxford University Hospitals NHS Foundation Trust, Oxford, UK
2 Moorfields Eye Hospital NHS Foundation Trust, London, UK
10.15171/ijhpm.2017.59
Abstract
New health technologies require development and evaluation ahead of being incorporated into the patient care pathway. In light of the recent publication by Lehoux et al who discuss the role of entrepreneurs, investors and regulators in providing value to new health technologies, we summarise the processes involved in making new health technologies available for use in the United Kingdom.
Keywords
Health Technology
Health Technology Assessment (HTA)
National Institute of Health Research (NIHR)
National Institute for Health and Care Excellence (NICE)
Subjects
  1. Parvizi N, Woods K. Regulation of medicines and medical devices: contrasts and similarities. Clin Med (Lond). 2014;14(1):6-12. doi:10.7861/clinmedicine.14-1-6
  2. Sculpher M, Claxton K, Drummond M, McCabe C. Whither trial-based economic evaluation for health care decision making? Health Econ. 2006;15:677-687.
  3. Lehoux P, Miller FA, Daudeline G, Denis JL. Providing value to new health technology: the early contribution of entrepreneurs, investors, and regulatory agencies. Int J Health Policy Manag. 2017; Forthcoming.
  4. National Institute for Health Research. Health Technology Assessment (HTA) Programme http://www.nihr.ac.uk/funding-and-support/funding-for-research-studies/funding-programmes/health-technology-assessment/.  Accessed May 1, 2017.
  5. National Institute for Health Research. Health Technology Assessment (HTA) Programme http://www.nets.nihr.ac.uk/programmes/hta.  Accessed February 22, 2017.
  6. National Institute for Health and Care Excellence website. http://www.nice.org.uk.  Accessed February 21, 2017.
  7. Guidance on Technology Appraisal. National Institute for Health and Care Excellence website. https://www.nice.org.uk/about/what-we-do/our-programmes/nice-guidance/nice-technology-appraisal-guidance.  Accessed February 27, 2017.
  8. Guidance on Highly Specialised Technologies. National Institute for Health and Care Excellence website. https://www.nice.org.uk/about/what-we-do/our-programmes/nice-guidance/nice-highly-specialised-technologies-guidance.  Accessed February 27, 2017.
  9. UK PharmaScan website. https://www.ukpharmascan.org.uk.  Accessed May 1, 2017.
  10. Accelerated Access Review. https://www.gov.uk/government/organisations/accelerated-access-review.   Accessed May 1, 2017
  11. Institution of Mechanical Engineers. Medical Devices and CE Marking the Impact of Brexit. London: The Institution of Mechanical Engineers; 2017. http://www.imeche.org/docs/default-source/1-oscar/reports-policy-statements-and-documents/medical-devices-ce-marking-the-impact-of-brexit.pdf?sfvrsn=0
International Journal of Health Policy and Management
Volume 6, Issue 12
2017
Pages 721-722

  • Received Date 27 February 2017
  • Revised Date 06 May 2017
  • Accepted Date 06 May 2017
  • First Published Date 01 December 2017
  • Published Date 01 December 2017